All In MedTech

Device Trial Radar · NCT07398157

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

Subgaleal Cortical Electrodes in Patients With Parkinson's Disease Undergoing Deep-brain Stimulation Therapy for Sensing and Adaptive Deep-brain Stimulation Over a 24-hour Period.

Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Apr 9, 2026

Primary completion

Nov 30, 2029

Study completion Nov 30, 2031

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Feb 9, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Crossover
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect useful brain signals? Find out if these brain signals can be related to movement and/or sleep symptoms. * How to use these brain signals to tailor adaptive deep brain stimulation settings for movement and/or sleep symptoms Researchers will compare study derived adaptive DBS settings to subject's clinically programmed continuous DBS settings to see which is better at treating patients PD symptoms.

Conditions

  • PD - Parkinson's Disease

Interventions

  • Medtronic Percept Deep Brain Stimulation (cDBS)Device

    Using the Percept pulse generator, patients receive clinically-optimized open loop stimulation to the subthalmaic nucleus.

  • Medtronic Percept Deep Brain Stimulation (daytime aDBS)Device

    Using the Percept pulse generator, patients receive daytime adaptive stimulation to the subthalmaic nucleus.

  • Medtronic Percept Deep Brain Stimulation (nighttime aDBS)Device

    Using the Percept pulse generator, patients receive nighttime adaptive stimulation to the subthalmaic nucleus.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in number of bothersome movement and/or sleep episodes on adaptive deep brain stimulation compared to open-loop deep brain stimulationTime frame: Baseline, aDBS testing, and during Blinded Assessment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California San Francisco

    San Francisco, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.